We remind you that the Health Plan adheres to the U.S. Preventative Services Task Force (USPSTF) recommendation for colorectal cancer screening, which was updated on May 18, 2021, to include adults aged 45 to 49 years who are of average risk for colon cancer. 

Excellus BlueCross BlueShield in partnership with eviCore healthcare MSI, an independent company, is closely monitoring the global shortage of iodinated contrast media and is aligned with recent recommendations from the American College of Radiology Committee (ACR) on Drugs and Contrast Media. 

Thanks to your feedback, we were made aware of an issue with electronic claim submissions where some claims were being rejected due to discrepancies between the information submitted and the information printed on the member card.